Haemophilia, Blood Products and HIV Infection

@article{Lowe1987HaemophiliaBP,
  title={Haemophilia, Blood Products and HIV Infection},
  author={G. Lowe},
  journal={Scottish Medical Journal},
  year={1987},
  volume={32},
  pages={109 - 111}
}
  • G. Lowe
  • Published 1987
  • Medicine
  • Scottish Medical Journal
Between 1979 and 1984, many haemophiliacs in the UK were exposed to the human immunodeficiency virus (HIV) by transfusion of blood products, in particular clotting factor concentrates, especially those imported from the USA. In the UK 1025 haemophiliacs are HIV-antibody-positive, of whom 75 are in Scotland. Thirty-one UK haemophiliacs have developed the Acquired Immune Deficiency Syndrome (AIDS), of whom 23 have died. The clinical progress of HIV infection appears similar in haemophiliacs and… Expand
Quantifying the source of infection for HIV-infected hemophiliacs in the U.K. from 1979 to 1984.
There is considerable literature on the risk of HIV infection for individuals suffering from hemophilia A in the United Kingdom (U.K.) during the period 1979-1984 when the sources of Factor VIIIExpand
Transmission of retroviral infection by transfusion of seronegative blood in nonhuman primates.
TLDR
The data suggest caution in the sole use of serologic tests for the detection of retroviral infection and document the ability of such blood samples to transmit infection. Expand
Psychiatric problems in HIV-infected men with haemophilia
The clinical aspects of haemophilia and its relationship to HIV disease are reviewed, together with discussion of general aspects of the disease progression in men with haemophilia, and transmissionExpand
Hepatitis C Virus Infection in Scotland: Epidemiological Review and Public Health Challenges
TLDR
Scotland faces three principal public health challenges: i) the prevention ofHCV among current IDUs, ii) the diagnosis of HCV-infected persons, particularly those most in need of therapy to prevent severe HCV disease, and iii) the current and future provision of adequate resources to ensure that the movement of patients through the diagnostic and clinical care pathway is optimal. Expand
Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in Scotland
TLDR
Age less than 34 years, year of diagnosis between 2004 and 2008, Greater Glasgow and Clyde, Grampian, Lanarkshire and Lothian Health boards were sufficient to predict HCV status in Scotland, with Injecting Drug Use (IDU) behaviour being the most prevalent risk factor. Expand
Modelling the hepatitis C virus disease burden among injecting drug users in Scotland
TLDR
A forward projection model was used to estimate the numbers of, both current and former, IDUs who acquired HCV infection and progressed to mild, moderate and severe HCV disease in Glasgow and Scotland between 1960 and 2030, and potentially as many as 4,500 HCV infections had been prevented in Glasgow during 1988-2000 as a result of harm-reduction measures. Expand
Children diagnosed with HIV on antiretroviral therapy in Ethiopia:The family caregivers’ lived experience and treatment outcome
TLDR
The findings from this thesis revealed that the need of support for family caregivers during their child’s HIV diagnosis and treatment initiation is part of a continuum of care. Expand
Kaposi's Sarcoma: A Clinico-Pathologic Overview
TLDR
A careful overview of the classical appearances of Kaposi's sarcoma as well as of its variants were reviewed from the clinical and pathological point of view and the dilemma of whether KS is a neoplasia or a hyperplasia is discussed. Expand

References

SHOWING 1-9 OF 9 REFERENCES
AIDS and haemophilia.
TLDR
The outlook for uninfected haemophiliacs with regard to AIDS is now good and treatment policies using heat-treated factor concentrates and the impact of donor screening are reviewed. Expand
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.
TLDR
It is shown that clotting factor concentrate impairs the cell mediated immune response to a new antigen in the absence of infection with HIV. Expand
HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USA
TLDR
Data indicate that European haemophiliacs were exposed to HTLV-III via some factor VIII concentrates obtained from the USA through both locally prepared concentrate and commercial concentrate made from US donor material. Expand
Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
TLDR
Scottish patients with haemophilia were found to have immunological abnormalities similar to those in their American counterparts, which argue against a disease vector specific to American blood products. Expand
HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII
Fifteen haemophiliac patients acquired antibodies to human T-lymphotropic virus type III during 1984. One batch of factor VIII concentrate given to all these patients is presumed to be the cause ofExpand
HIV infection in the Edinburgh cohort of haemophiliacs
  • Abstracts of Meeting of British Society for Haemostasis and Thrombosis,
  • 1987
HIV infection in the Edinburgh cohort of haemophiliacs
  • Abstracts of Meeting of British Society for Haemostasis and Thrombosis,
  • 1987
Latest UK figures for AIDS
  • Lancet
  • 1987
Latest UK figures for AIDS
  • Lancet
  • 1987